Astratus
Reading, GB · 1 known investors
Astratus develops a semi-automated laboratory platform using a microcapillary "dip and test" cassette and instrument reader for rapid antimicrobial susceptibility testing (AST), delivering results in under 6 hours directly from urine or bacterial isolates. It serves human, veterinary, and research markets, supporting clinical laboratories with antimicrobial stewardship and researchers developing new antimicrobials and therapies.
Founders & leadership
DO
Dr Oliver HancoxChief Executive Officer
Investors · 1
Frequently asked questions
- What does Astratus do?
- Astratus develops a semi-automated laboratory platform using a microcapillary "dip and test" cassette and instrument reader for rapid antimicrobial susceptibility testing (AST), delivering results in under 6 hours directly from urine or bacterial isolates. It serves human, veterinary, and research markets, supporting clinical laboratories with antimicrobial stewardship and researchers developing new antimicrobials and therapies.
- Who are Astratus's investors?
- Astratus's investors include Jenson Ventures.
- Where is Astratus headquartered?
- Astratus is headquartered in Reading, GB.